Medesis Pharma S.A.
Clinical-stage biotech developing treatments using its AONYS® drug delivery platform.
ALMDP | PA
Overview
Corporate Details
- ISIN(s):
- FR0010844464
- LEI:
- 969500C15M96P00UR648
- Country:
- France
- Address:
- AVENUE DU GOLF, 34670 BAILLARGUES
- Website:
- https://www.medesispharma.com/
- Sector:
- Manufacturing
Description
Medesis Pharma is a clinical-stage pharmaceutical biotechnology company focused on developing treatments for serious diseases using its proprietary AONYS® drug delivery platform. The AONYS® technology is a micro-emulsion designed for buccal (oral) administration, enabling the intracellular delivery of various therapeutic molecules, including metal ions, interfering RNAs, and peptides. A key feature of the platform is its ability to transport active ingredients across the blood-brain barrier, making it a promising approach for neurological disorders. The company's development pipeline addresses diseases with high unmet medical needs, including neurodegenerative conditions like Alzheimer's disease and therapies for individuals exposed to nuclear radiation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-27 18:00 |
MEDESIS PHARMA : Rapport Financier Annuel 2022
|
French | 5.7 MB | ||
| 2023-04-17 08:00 |
MEDESIS PHARMA : 2022 FULL-YEAR BUSINESS AND EARNINGS
|
English | 759.3 KB | ||
| 2023-04-17 08:00 |
MEDESIS PHARMA : ACTIVITÉS & RÉSULTATS ANNUELS 2022
|
French | 235.7 KB | ||
| 2023-04-04 08:00 |
MEDESIS PHARMA SIGNS A PARTNERSHIP WITH PARTNER INTERNATIONAL, WORLD LEADER IN …
|
English | 304.5 KB | ||
| 2023-04-04 08:00 |
MEDESIS PHARMA SIGNE UN PARTENARIAT AVEC PARTNER INTERNATIONAL, LEADER MONDIAL…
|
French | 353.5 KB | ||
| 2023-03-31 08:00 |
MEDESIS PHARMA MET EN PLACE UN FINANCEMENT OBLIGATAIRE D’UN MONTANT NOMINAL MA…
|
French | 2.4 MB | ||
| 2023-03-13 08:00 |
MEDESIS PHARMA PRESENTE UN POSTER SCIENTIFIQUE AU CONGRES RNA LEADERS EUROPE A…
|
French | 397.1 KB | ||
| 2023-03-13 08:00 |
MEDESIS PHARMA PRESENTS A SCIENTIFIC POSTER AT THE EUROPEAN RNA LEADERS CONGRES…
|
English | 349.2 KB | ||
| 2023-03-07 08:00 |
MEDESIS PHARMA: NEW PATENT FILED PROTECTING THE TECHNICAL OPTIMIZATION OF THE A…
|
English | 330.4 KB | ||
| 2023-03-07 08:00 |
MEDESIS PHARMA : DÉPOT D’UN NOUVEAU BREVET PROTÉGEANT L’OPTIMISATION TECHNIQUE …
|
French | 376.2 KB | ||
| 2023-01-05 18:00 |
MEDESIS PHARMA : BILAN SEMESTRIEL S2 2022 DU CONTRAT DE LIQUIDITE
|
French | 1.0 MB | ||
| 2023-01-05 18:00 |
MEDESIS PHARMA CONFIRME SON ELIGIBILITE AU PEA-PME
|
French | 243.6 KB | ||
| 2022-12-12 18:00 |
MEDESIS PHARMA: PATENT REGISTERED IN EURASIA TO PROTECT THE CESIUM DECORPORATIO…
|
English | 402.4 KB | ||
| 2022-12-12 18:00 |
MEDESIS PHARMA : ENREGISTREMENT EN EURASIE DU BREVET DE PROTECTION DU CANDIDAT …
|
French | 487.6 KB | ||
| 2022-11-28 18:00 |
MEDESIS PHARMA PRESENTS A SCIENTIFIC POSTER AT THE CLINICAL TRIALS ON ALZHEIMER…
|
English | 387.4 KB |
Automate Your Workflow. Get a real-time feed of all Medesis Pharma S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medesis Pharma S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medesis Pharma S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-16 | N/A | Other | Sell | 1,000 | 1,170.00 EUR |
| 2024-01-18 | N/A | Other | Sell | 800 | 669.60 EUR |
| 2023-07-21 | N/A | Other | Sell | 1,000 | 1,400.00 EUR |
| 2023-07-04 | N/A | Other | Sell | 5,000 | 7,100.00 EUR |
| 2023-05-23 | N/A | Other | Sell | 3,140 | 6,908.00 EUR |
Peer Companies
